Arcutis Biotherapeutics, Inc. ARQT Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s total debt?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total debt of $114.67M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s total debt changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total debt increased by 3.5% year-over-year, from $110.8M to $114.67M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total debt?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s total debt has grown at a 87.3% compound annual growth rate (CAGR), from $4.96M to $114.52M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.